홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
STXS
#3668
Stereotaxis, Inc. Common Stock
2.020
0
USD
+4.39%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+4.39%
월간 변동
+4.68%
6달 변화
-2.88%
년간 변동율
-2.88%
이전 종가
1.935
0
Open
2.010
0
Bid
Ask
Low
2.000
0
High
2.040
0
양
143
마켓
주식
헬스케어
STXS
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
73.76 M
74.64 M
75.05 M
82.13 M
85.98 M
97.25 M
—
Valuation ratios
Enterprise value
333.66 M
424.02 M
149.02 M
133.76 M
183.82 M
210.25 M
815.97 M
Price to earnings ratio
-46.27
-38.75
-8.08
-6.93
-7.6
-9.2
-33.29
Price to sales ratio
13.87
13.38
5.58
5.42
7.03
6.37
26.44
Price to cash flow ratio
-105.44
-159.02
-18.98
-16.51
-22.86
-15.29
-89.16
Price to book ratio
10.7
13.85
6.06
9.23
31.94
15.52
45.41
EBITDA 비율에 대한 기업 가치
-51.34
-33.62
-8.28
-6.55
-7.97
-10.47
-37.78
Profitability ratios
Return on assets %
-0.12
-0.18
-0.34
-0.49
-0.51
-0.41
-0.47
Return on equity %
-0.19
-0.32
-0.69
-1.27
-3.95
-1.61
-6.09
Return on invested capital %
-227.69
-373.1
-434.78
-508.83
-402.05
-263.14
—
Gross margin %
71.04
66.36
64.51
53.32
52.85
51.98
208.46
Operating margin %
-25.15
-36.81
-65.58
-78.37
-89.6
-67.32
-273.94
EBITDA margin %
-24.42
-36.54
-62.84
-73.33
-83.57
-61.17
-232.91
Net margin %
-24.9
-30.61
-63.89
-74.33
-87.08
-65.9
-268.27
Liquidity ratios
Quick ratio
3.64
3.54
2.47
1.88
0.84
1.09
3.15
Current ratio
3.88
3.87
3.03
2.51
1.22
1.51
4.95
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.54
0.6
0.5
0.58
0.62
0.66
0.72
Solvency ratios
Debt to assets ratio
0.04
0
—
—
—
—
—
Debt to equity ratio
0.06
0
—
—
—
—
—
Long term debt to total assets ratio
0.02
0
—
—
—
—
—
Long term debt to total equity ratio
0.03
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.05
-0.04
-0.11
-0.11
-0.1
-0.15
-0.15
EBIT per share
-0.09
-0.17
-0.24
-0.26
-0.28
-0.24
-0.24
EBITDA per share
-0.09
-0.17
-0.24
-0.25
-0.27
-0.22
-0.21
Total debt per share
0.03
0
—
—
—
—
—
Cash per share
0.6
0.51
0.37
0.25
0.14
0.15
0.46
Net current asset value per share
0.72
0.68
0.57
0.41
0.31
0.37
1.21
Tangible book value per share
0.48
0.45
0.35
0.2
-0.06
0.04
-0.21
Working capital per share
0.54
0.5
0.38
0.25
0.06
0.13
0.23
Book value per share
0.48
0.45
0.35
0.2
0.07
0.15
0.27
뉴스
Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS)
Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
Stereotaxis Q1 실적 예상치와 일치, 수익 에상치보다 저조
Stereotaxis earnings matched, revenue fell short of estimates
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates
Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026?
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates
Beta Bionics, Inc. (BBNX) Reports Q4 Loss, Tops Revenue Estimates
FDA, 쉴드 테라퓨틱스 ACCRUFeR에 3년 독점권 추가 부여
FDA grants additional 3-year exclusivity for Shield’s ACCRUFeR